iguratimod has been researched along with osteoprotegerin in 1 studies
Studies (iguratimod) | Trials (iguratimod) | Recent Studies (post-2010) (iguratimod) | Studies (osteoprotegerin) | Trials (osteoprotegerin) | Recent Studies (post-2010) (osteoprotegerin) |
---|---|---|---|---|---|
134 | 19 | 109 | 5,108 | 212 | 2,726 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bi, LQ; Ding, R; Li, P; Wang, XT; Xu, TS; Zhang, X | 1 |
1 other study(ies) available for iguratimod and osteoprotegerin
Article | Year |
---|---|
Effect of iguratimod and methotrexate on RANKL and OPG expression in serum and IL-1β-induced fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Blotting, Western; Chromones; Enzyme-Linked Immunosorbent Assay; Female; Fibroblasts; Humans; Interleukin-1beta; Male; Methotrexate; Middle Aged; Osteoprotegerin; RANK Ligand; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Synoviocytes | 2016 |